These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 29691238)

  • 41. Metabolic activation of the indoloquinazoline alkaloids evodiamine and rutaecarpine by human liver microsomes: dehydrogenation and inactivation of cytochrome P450 3A4.
    Wen B; Roongta V; Liu L; Moore DJ
    Drug Metab Dispos; 2014 Jun; 42(6):1044-54. PubMed ID: 24696463
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Hyperhomocysteinemia activates the aryl hydrocarbon receptor/CD36 pathway to promote hepatic steatosis in mice.
    Yao L; Wang C; Zhang X; Peng L; Liu W; Zhang X; Liu Y; He J; Jiang C; Ai D; Zhu Y
    Hepatology; 2016 Jul; 64(1):92-105. PubMed ID: 26928949
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Synthesis, physicochemical and pharmacological properties of pentacyclic alkaloid-analogues].
    Bubenyák M
    Acta Pharm Hung; 2011; 81(4):139-49. PubMed ID: 22329301
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Knockout of the aryl hydrocarbon receptor results in distinct hepatic and renal phenotypes in rats and mice.
    Harrill JA; Hukkanen RR; Lawson M; Martin G; Gilger B; Soldatow V; Lecluyse EL; Budinsky RA; Rowlands JC; Thomas RS
    Toxicol Appl Pharmacol; 2013 Oct; 272(2):503-18. PubMed ID: 23859880
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Rutaecarpine administration inhibits cancer cell growth in allogenic TRAMP-C1 prostate cancer mice correlating with immune balance in vivo.
    Lin JY; Yeh TH
    Biomed Pharmacother; 2021 Jul; 139():111648. PubMed ID: 33945915
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Identification of a high-affinity ligand that exhibits complete aryl hydrocarbon receptor antagonism.
    Smith KJ; Murray IA; Tanos R; Tellew J; Boitano AE; Bisson WH; Kolluri SK; Cooke MP; Perdew GH
    J Pharmacol Exp Ther; 2011 Jul; 338(1):318-27. PubMed ID: 21493753
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Aryl Hydrocarbon Receptor Ligand Activity of Extracts from 62 Herbal Medicines and Effect on Cytochrome P450 Activity].
    Harada A; Sugihara K; Watanabe Y; Yamaji S; Kitamura S; Ohta S
    Yakugaku Zasshi; 2015; 135(10):1185-96. PubMed ID: 26423875
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Dexamethasone accelerates degradation of aryl hydrocarbon receptor (AHR) and suppresses CYP1A1 induction in placental JEG-3 cell line.
    Stejskalova L; Rulcova A; Vrzal R; Dvorak Z; Pavek P
    Toxicol Lett; 2013 Nov; 223(2):183-91. PubMed ID: 24091107
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The aryl hydrocarbon receptor directly regulates expression of the potent mitogen epiregulin.
    Patel RD; Kim DJ; Peters JM; Perdew GH
    Toxicol Sci; 2006 Jan; 89(1):75-82. PubMed ID: 16192470
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Inhibition of the aryl hydrocarbon receptor prevents Western diet-induced obesity. Model for AHR activation by kynurenine via oxidized-LDL, TLR2/4, TGFβ, and IDO1.
    Moyer BJ; Rojas IY; Kerley-Hamilton JS; Hazlett HF; Nemani KV; Trask HW; West RJ; Lupien LE; Collins AJ; Ringelberg CS; Gimi B; Kinlaw WB; Tomlinson CR
    Toxicol Appl Pharmacol; 2016 Jun; 300():13-24. PubMed ID: 27020609
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Comprehensive Analysis of 11 Species of
    Yong X; Wang B; Wang M; Lyu H; Yin M; Jin T; Feng X; Shan Y; Liang Y; Wang Q
    Molecules; 2024 Feb; 29(5):. PubMed ID: 38474571
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Norisoboldine, a natural aryl hydrocarbon receptor agonist, alleviates TNBS-induced colitis in mice, by inhibiting the activation of NLRP3 inflammasome.
    Lv Q; Wang K; Qiao SM; Dai Y; Wei ZF
    Chin J Nat Med; 2018 Mar; 16(3):161-174. PubMed ID: 29576052
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Indoxyl sulfate suppresses hepatic fetuin-A expression via the aryl hydrocarbon receptor in HepG2 cells.
    Ochi A; Mori K; Nakatani S; Emoto M; Morioka T; Motoyama K; Fukumoto S; Imanishi Y; Shoji T; Ishimura E; Inaba M
    Nephrol Dial Transplant; 2015 Oct; 30(10):1683-92. PubMed ID: 26068716
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Activation of the aryl hydrocarbon receptor induces hepatic steatosis via the upregulation of fatty acid transport.
    Kawano Y; Nishiumi S; Tanaka S; Nobutani K; Miki A; Yano Y; Seo Y; Kutsumi H; Ashida H; Azuma T; Yoshida M
    Arch Biochem Biophys; 2010 Dec; 504(2):221-7. PubMed ID: 20831858
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Development and validation of HPLC methods for the analysis of phenethylamine and indoloquinazoline alkaloids in Evodia species.
    Pellati F; Benvenuti S; Yoshizaki F; Melegari M
    J Sep Sci; 2006 Mar; 29(5):641-9. PubMed ID: 16605082
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Evodiamine: a novel anti-cancer alkaloid from Evodia rutaecarpa.
    Jiang J; Hu C
    Molecules; 2009 May; 14(5):1852-9. PubMed ID: 19471205
    [TBL] [Abstract][Full Text] [Related]  

  • 57. In vitro screening for aryl hydrocarbon receptor agonistic activity in 200 pesticides using a highly sensitive reporter cell line, DR-EcoScreen cells, and in vivo mouse liver cytochrome P450-1A induction by propanil, diuron and linuron.
    Takeuchi S; Iida M; Yabushita H; Matsuda T; Kojima H
    Chemosphere; 2008 Dec; 74(1):155-65. PubMed ID: 18835618
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Evidence for an aryl hydrocarbon receptor-mediated cytochrome p450 autoregulatory pathway.
    Chiaro CR; Patel RD; Marcus CB; Perdew GH
    Mol Pharmacol; 2007 Nov; 72(5):1369-79. PubMed ID: 17720764
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Quinolone and indole alkaloids from the fruits of Euodia rutaecarpa and their cytotoxicity against two human cancer cell lines.
    Zhao N; Li ZL; Li DH; Sun YT; Shan DT; Bai J; Pei YH; Jing YK; Hua HM
    Phytochemistry; 2015 Jan; 109():133-9. PubMed ID: 25457491
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Xenobiotics and loss of cell adhesion drive distinct transcriptional outcomes by aryl hydrocarbon receptor signaling.
    Hao N; Lee KL; Furness SG; Bosdotter C; Poellinger L; Whitelaw ML
    Mol Pharmacol; 2012 Dec; 82(6):1082-93. PubMed ID: 22936816
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.